DesignMedix, Inc. develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. Diseases like malaria and diarrhea kill millions of people each year and cause untold suffering. The World Health Organization considers drug-resistance to be one of the top three threats to human health today. From the miracle drugs of almost 100 years ago, we are now facing super bugs that can withstand many of the antibiotics that we have available. Because the regular drugs no longer work, costs are rising with the use of stronger drugs and more people are dying when even the strongest therapies do not kill the resistant pathogens. Using proprietary technology, DesignMedix is developing novel drugs to help efforts to alleviate and eliminate these infections.
Funding Rounds (4) - $12.7MUpdate
The Problem Solving Company
Oregon Angel Fund (OAF) is a community-supported, professionally-managed and investor-driven...
The Portland Seed Fund finds and surrounds the most promising seed-stage companies with capital.
2828 SW Corbett Avenue
Portland, OR 97201